Researchers at Kumamoto University have developed a blood test capable of detecting breast cancer recurrence by studying nucleosomes and circulating free DNA, which could facilitate the monitoring of patients in a minimally invasive manner and allow for more personalized therapeutic decisions, although further studies are needed to validate its clinical applicability. (translated)















